NATA - Nucleic Acid Therapy Accelerator

The Nucleic Acid Therapy Accelerator (NATA) is a new national research initiative with a mission to accelerate the development of nucleic acid therapeutics, while firmly anchoring the nucleic acid (NA) therapy industry in the UK for many years to come. The NATA will be at the Harwell Science and Innovation Campus, at the heart of a growing Life Health Cluster. It will benefit from and contribute to the campus world-class scientific talent, ecosystem and related facilities, including the Research Complex at Harwell and the new Rosalind Franklin Institute

Nata - nucleic acid therapy accelerator operates in the Research services industry.

Nata - nucleic acid therapy accelerator's revenue is 11m - 100m

Nata - nucleic acid therapy accelerator has 11 - 50 employees.